KARRI RAY: Open Payments
NPI 1144257379 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,278 in 158 payments from 14 companies in 2025. Trend: 2023 $1,703 · 2024 $2,292 · 2025 $3,278
Food & beverage: $3,278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $898 |
| Janssen Biotech, Inc. | 14 | $440 |
| Madrigal Pharmaceuticals | 14 | $372 |
| QOL Medical, LLC | 22 | $353 |
| Ardelyx, Inc. | 18 | $325 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $269 |
| Phathom Pharmaceuticals, Inc. | 9 | $244 |
| Gilead Sciences, Inc. | 4 | $90 |
| Ipsen Biopharmaceuticals, Inc | 3 | $69 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
Products named: TREMFYA, REZDIFFRA, Sucraid, IBSRELA, RINVOQ, LINZESS, ENTYVIO, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
